ZD6126: A novel small molecule vascular targeting agentBLAKEY, David C; ASHTON, Susan E; WESTWOOD, F. Russell et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 5, pp 1497-1502, issn 0360-3016, 6 p.Conference Paper

Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor modelsBLAKEY, David C; WESTWOOD, F. Russell; WALKER, Mike et al.Clinical cancer research. 2002, Vol 8, Num 6, pp 1974-1983, issn 1078-0432Article

Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lung adenocarcinoma in nude miceGOTO, Hisatsugu; YANO, Seiji; HELONG ZHANG et al.Cancer research (Baltimore). 2002, Vol 62, Num 13, pp 3711-3715, issn 0008-5472Article

Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126EVELHOCH, Jeffrey L; LORUSSO, Patricia M; RYAN, Anderson J et al.Clinical cancer research. 2004, Vol 10, Num 11, pp 3650-3657, issn 1078-0432, 8 p.Article

DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767MONKS, Noel R; BLAKEY, David C; EAST, Simon J et al.European journal of cancer (1990). 2002, Vol 38, Num 11, pp 1543-1552, issn 0959-8049Article

ZD6126: A novel vascular-targeting agent that causes selective destruction of tumor vasculatureDAVIS, Peter D; DOUGHERTY, Graeme J; HILL, Sally A et al.Cancer research (Baltimore). 2002, Vol 62, Num 24, pp 7247-7253, issn 0008-5472, 7 p.Article

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in OncologyPRABHAKAR, Uma; MAEDA, Hiroshi; JAIN, Rakesh K et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 8, pp 2412-2417, issn 0008-5472, 6 p.Article

Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor GrowthJIN GAO; CHESEBROUGH, Jon W; COATS, Steven et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 3, pp 1029-1040, issn 0008-5472, 12 p.Article

Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatinGOTO, Hisatsugu; YANO, Seiji; MATSUMORI, Yuka et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7671-7676, issn 1078-0432, 6 p.Article